GRIN2B and depressive disorder: Gentiopicroside alleviates pain-depression comorbidity in reserpine-induced models by downregulating glutamate NMDA receptor subunit 2B (GluN2B) subunit expression of NMDA receptors in the basolateral amygdala, reducing glutamatergic excitotoxicity.